Ginkgo Bioworks Holdings (DNA) Sales of Property, Plant and Equipment (2022 - 2025)

Ginkgo Bioworks Holdings (DNA) Sales of Property, Plant and Equipment (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 27,000.00
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Ginkgo Bioworks Holdings 445.24 Mn 301.37 Mn 16.38 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 574,000.00
Dec 31, 2025 574,000.00
Dec 31, 2024 57,000.00
Dec 31, 2024 57,000.00
Sep 30, 2024 400,000.00
Sep 30, 2024 400,000.00
Dec 31, 2023 1.43 Mn
Dec 31, 2023 1.43 Mn
Sep 30, 2023 74,000.00
Sep 30, 2023 74,000.00
Jun 30, 2023 2.31 Mn
Jun 30, 2023 2.31 Mn
Mar 31, 2023 617,000.00
Mar 31, 2023 617,000.00
Dec 31, 2022 -110,000.00
Dec 31, 2022 -110,000.00
Sep 30, 2022 110,000.00
Sep 30, 2022 110,000.00
Jun 30, 2022 -58,000.00
Jun 30, 2022 -58,000.00